Structure

Physi-Chem Properties

Molecular Weight:  430.24
Volume:  440.369
LogP:  4.876
LogD:  3.704
LogS:  -4.149
# Rotatable Bonds:  0
TPSA:  96.22
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  5
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.546
Synthetic Accessibility Score:  4.793
Fsp3:  0.72
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.008
MDCK Permeability:  1.7870597730507143e-05
Pgp-inhibitor:  0.926
Pgp-substrate:  0.987
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.006
30% Bioavailability (F30%):  0.035

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.517
Plasma Protein Binding (PPB):  92.0923843383789%
Volume Distribution (VD):  1.036
Pgp-substrate:  7.603910446166992%

ADMET: Metabolism

CYP1A2-inhibitor:  0.131
CYP1A2-substrate:  0.122
CYP2C19-inhibitor:  0.025
CYP2C19-substrate:  0.298
CYP2C9-inhibitor:  0.272
CYP2C9-substrate:  0.627
CYP2D6-inhibitor:  0.088
CYP2D6-substrate:  0.271
CYP3A4-inhibitor:  0.183
CYP3A4-substrate:  0.183

ADMET: Excretion

Clearance (CL):  12.114
Half-life (T1/2):  0.2

ADMET: Toxicity

hERG Blockers:  0.759
Human Hepatotoxicity (H-HT):  0.816
Drug-inuced Liver Injury (DILI):  0.108
AMES Toxicity:  0.017
Rat Oral Acute Toxicity:  0.969
Maximum Recommended Daily Dose:  0.989
Skin Sensitization:  0.512
Carcinogencity:  0.293
Eye Corrosion:  0.003
Eye Irritation:  0.021
Respiratory Toxicity:  0.963

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472621

Natural Product ID:  NPC472621
Common Name*:   YMGGKEHLQJSJSU-CJVWRCMMSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  YMGGKEHLQJSJSU-CJVWRCMMSA-N
Standard InCHI:  InChI=1S/C25H34O6/c1-12-8-14-13-9-18-24(4)7-6-19(27)23(2,3)17(24)11-20(28)25(18,5)31-16(13)10-15(26)21(14)22(29)30-12/h10,12,17-20,26-28H,6-9,11H2,1-5H3/t12-,17+,18+,19+,20+,24+,25-/m1/s1
SMILES:  C[C@H]1OC(=O)c2c(C1)c1C[C@@H]3[C@](Oc1cc2O)(C)[C@@H](O)C[C@@H]1[C@]3(C)CC[C@@H](C1(C)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3581317
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001538] Diterpene lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32870 penicillium funiculosum gwt2-24 Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[26046820]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT116 Cell Line HL-60 Homo sapiens IC50 > 50000.0 nM PMID[538898]
NPT111 Cell Line K562 Homo sapiens IC50 > 50000.0 nM PMID[538898]
NPT165 Cell Line HeLa Homo sapiens IC50 > 50000.0 nM PMID[538898]
NPT81 Cell Line A549 Homo sapiens IC50 > 50000.0 nM PMID[538898]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 600.0 ug.mL-1 PMID[538898]
NPT19 Organism Escherichia coli Escherichia coli MIC > 600.0 ug.mL-1 PMID[538898]
NPT1453 Organism Influenza A virus (A/PR/8/34(H1N1)) Influenza A virus (A/Puerto Rico/8/1934(H1N1)) IC50 = 57000.0 nM PMID[538898]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472621 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9936 High Similarity NPC472622
0.9625 High Similarity NPC472619
0.9509 High Similarity NPC294149
0.9506 High Similarity NPC472620
0.9367 High Similarity NPC472617
0.9313 High Similarity NPC473022
0.9187 High Similarity NPC472618
0.9141 High Similarity NPC125465
0.9125 High Similarity NPC470339
0.9068 High Similarity NPC472055
0.8994 High Similarity NPC472799
0.8944 High Similarity NPC272196
0.8931 High Similarity NPC167903
0.8929 High Similarity NPC63105
0.8916 High Similarity NPC102810
0.8909 High Similarity NPC469394
0.8889 High Similarity NPC239118
0.8889 High Similarity NPC4950
0.8882 High Similarity NPC164427
0.8882 High Similarity NPC4547
0.8876 High Similarity NPC324220
0.8876 High Similarity NPC312630
0.8868 High Similarity NPC473131
0.8868 High Similarity NPC470675
0.8862 High Similarity NPC251144
0.8862 High Similarity NPC241387
0.8862 High Similarity NPC298778
0.8855 High Similarity NPC474024
0.8848 High Similarity NPC293319
0.883 High Similarity NPC208069
0.883 High Similarity NPC475161
0.883 High Similarity NPC477860
0.8817 High Similarity NPC474345
0.8812 High Similarity NPC113608
0.8812 High Similarity NPC470337
0.8812 High Similarity NPC470338
0.8812 High Similarity NPC268992
0.8812 High Similarity NPC51824
0.8805 High Similarity NPC150928
0.8795 High Similarity NPC472452
0.879 High Similarity NPC473132
0.879 High Similarity NPC470676
0.879 High Similarity NPC473023
0.879 High Similarity NPC473135
0.8788 High Similarity NPC476295
0.8788 High Similarity NPC12461
0.8786 High Similarity NPC221140
0.8786 High Similarity NPC473686
0.8786 High Similarity NPC475352
0.8786 High Similarity NPC475220
0.8786 High Similarity NPC229817
0.878 High Similarity NPC97812
0.8779 High Similarity NPC473631
0.8779 High Similarity NPC475662
0.8779 High Similarity NPC293227
0.8779 High Similarity NPC473717
0.8773 High Similarity NPC473990
0.8773 High Similarity NPC474373
0.8772 High Similarity NPC84494
0.8772 High Similarity NPC245059
0.8765 High Similarity NPC478050
0.8765 High Similarity NPC46958
0.8765 High Similarity NPC477674
0.8757 High Similarity NPC213052
0.875 High Similarity NPC474021
0.875 High Similarity NPC478148
0.875 High Similarity NPC241874
0.875 High Similarity NPC474023
0.875 High Similarity NPC477670
0.8743 High Similarity NPC225419
0.8743 High Similarity NPC117854
0.8743 High Similarity NPC218226
0.8743 High Similarity NPC6588
0.8743 High Similarity NPC249977
0.8743 High Similarity NPC477154
0.8742 High Similarity NPC237440
0.8742 High Similarity NPC270160
0.8727 High Similarity NPC206605
0.8727 High Similarity NPC211107
0.8727 High Similarity NPC473961
0.8727 High Similarity NPC15374
0.8726 High Similarity NPC470673
0.8726 High Similarity NPC470674
0.8726 High Similarity NPC117716
0.8721 High Similarity NPC470452
0.8721 High Similarity NPC470453
0.8721 High Similarity NPC164047
0.8721 High Similarity NPC470448
0.872 High Similarity NPC321399
0.872 High Similarity NPC470810
0.872 High Similarity NPC174953
0.8712 High Similarity NPC158542
0.8706 High Similarity NPC68381
0.8704 High Similarity NPC68727
0.8704 High Similarity NPC477958
0.8704 High Similarity NPC477687
0.8704 High Similarity NPC477671
0.8704 High Similarity NPC175192
0.8698 High Similarity NPC4200
0.8698 High Similarity NPC118128
0.8696 High Similarity NPC87708
0.8696 High Similarity NPC180944
0.8696 High Similarity NPC217447
0.8696 High Similarity NPC475790
0.8696 High Similarity NPC256141
0.8696 High Similarity NPC273483
0.869 High Similarity NPC300307
0.869 High Similarity NPC297195
0.869 High Similarity NPC291795
0.869 High Similarity NPC207574
0.8688 High Similarity NPC179178
0.8683 High Similarity NPC272502
0.8683 High Similarity NPC13481
0.8683 High Similarity NPC178173
0.8683 High Similarity NPC207575
0.8683 High Similarity NPC43319
0.8675 High Similarity NPC100849
0.8675 High Similarity NPC186686
0.8675 High Similarity NPC474240
0.8671 High Similarity NPC260946
0.8667 High Similarity NPC472632
0.8667 High Similarity NPC117985
0.8667 High Similarity NPC471211
0.8667 High Similarity NPC471212
0.8667 High Similarity NPC18380
0.8667 High Similarity NPC471210
0.8667 High Similarity NPC3629
0.8667 High Similarity NPC137232
0.8667 High Similarity NPC472906
0.8663 High Similarity NPC473785
0.8659 High Similarity NPC85121
0.8659 High Similarity NPC218818
0.8659 High Similarity NPC210459
0.8659 High Similarity NPC195167
0.8655 High Similarity NPC475246
0.8655 High Similarity NPC469345
0.865 High Similarity NPC208152
0.865 High Similarity NPC78492
0.865 High Similarity NPC472050
0.865 High Similarity NPC477675
0.8647 High Similarity NPC469393
0.8642 High Similarity NPC192189
0.8642 High Similarity NPC477669
0.8639 High Similarity NPC315306
0.8639 High Similarity NPC313717
0.8639 High Similarity NPC193698
0.8639 High Similarity NPC313304
0.8634 High Similarity NPC204561
0.8634 High Similarity NPC312549
0.8634 High Similarity NPC305965
0.8634 High Similarity NPC317715
0.8634 High Similarity NPC72958
0.8634 High Similarity NPC148945
0.8634 High Similarity NPC209142
0.8634 High Similarity NPC48671
0.8634 High Similarity NPC471677
0.8634 High Similarity NPC477672
0.8634 High Similarity NPC309512
0.8634 High Similarity NPC477673
0.8634 High Similarity NPC78835
0.8634 High Similarity NPC149526
0.8634 High Similarity NPC70016
0.8634 High Similarity NPC232645
0.8634 High Similarity NPC215921
0.8634 High Similarity NPC474417
0.8634 High Similarity NPC316960
0.8631 High Similarity NPC476306
0.8625 High Similarity NPC233267
0.8625 High Similarity NPC473016
0.8625 High Similarity NPC472628
0.8625 High Similarity NPC291049
0.8623 High Similarity NPC99216
0.8623 High Similarity NPC475888
0.8623 High Similarity NPC7752
0.8623 High Similarity NPC475979
0.8616 High Similarity NPC91902
0.8616 High Similarity NPC470670
0.8616 High Similarity NPC473133
0.8616 High Similarity NPC47388
0.8614 High Similarity NPC474033
0.8614 High Similarity NPC474034
0.8614 High Similarity NPC201800
0.8614 High Similarity NPC472402
0.8614 High Similarity NPC472964
0.8614 High Similarity NPC52204
0.8606 High Similarity NPC155302
0.8606 High Similarity NPC475784
0.8606 High Similarity NPC471976
0.8606 High Similarity NPC299436
0.8606 High Similarity NPC36217
0.8606 High Similarity NPC161947
0.8606 High Similarity NPC292863
0.8606 High Similarity NPC184326
0.8606 High Similarity NPC476280
0.8606 High Similarity NPC472630
0.8606 High Similarity NPC297212
0.8606 High Similarity NPC472631
0.8605 High Similarity NPC477683
0.8605 High Similarity NPC470334
0.8605 High Similarity NPC477682

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472621 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8667 High Similarity NPD6959 Discontinued
0.8528 High Similarity NPD7819 Suspended
0.8485 Intermediate Similarity NPD7075 Discontinued
0.8471 Intermediate Similarity NPD5844 Phase 1
0.8415 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8415 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8402 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8402 Intermediate Similarity NPD6166 Phase 2
0.8402 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8364 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8353 Intermediate Similarity NPD7473 Discontinued
0.8314 Intermediate Similarity NPD7074 Phase 3
0.8313 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8284 Intermediate Similarity NPD6232 Discontinued
0.8256 Intermediate Similarity NPD7054 Approved
0.8256 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD6801 Discontinued
0.8242 Intermediate Similarity NPD1934 Approved
0.8232 Intermediate Similarity NPD4380 Phase 2
0.8228 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8208 Intermediate Similarity NPD7472 Approved
0.8182 Intermediate Similarity NPD7411 Suspended
0.8148 Intermediate Similarity NPD2532 Approved
0.8148 Intermediate Similarity NPD2534 Approved
0.8148 Intermediate Similarity NPD2533 Approved
0.8125 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.8125 Intermediate Similarity NPD8312 Approved
0.8125 Intermediate Similarity NPD8313 Approved
0.8121 Intermediate Similarity NPD6599 Discontinued
0.8114 Intermediate Similarity NPD7251 Discontinued
0.8111 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD7768 Phase 2
0.8084 Intermediate Similarity NPD1465 Phase 2
0.8081 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8068 Intermediate Similarity NPD7808 Phase 3
0.8059 Intermediate Similarity NPD5494 Approved
0.8057 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8057 Intermediate Similarity NPD6797 Phase 2
0.8047 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD4628 Phase 3
0.7989 Intermediate Similarity NPD7228 Approved
0.7987 Intermediate Similarity NPD6099 Approved
0.7987 Intermediate Similarity NPD6100 Approved
0.7941 Intermediate Similarity NPD3749 Approved
0.7937 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7937 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7929 Intermediate Similarity NPD3817 Phase 2
0.7927 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.791 Intermediate Similarity NPD6559 Discontinued
0.7889 Intermediate Similarity NPD8150 Discontinued
0.7888 Intermediate Similarity NPD1549 Phase 2
0.787 Intermediate Similarity NPD2801 Approved
0.7866 Intermediate Similarity NPD6799 Approved
0.7865 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD8151 Discontinued
0.7844 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD3750 Approved
0.7784 Intermediate Similarity NPD3818 Discontinued
0.7778 Intermediate Similarity NPD3882 Suspended
0.7772 Intermediate Similarity NPD7783 Phase 2
0.7772 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD1511 Approved
0.7738 Intermediate Similarity NPD7458 Discontinued
0.773 Intermediate Similarity NPD2800 Approved
0.7725 Intermediate Similarity NPD5403 Approved
0.7719 Intermediate Similarity NPD5402 Approved
0.7706 Intermediate Similarity NPD37 Approved
0.7705 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7701 Intermediate Similarity NPD7199 Phase 2
0.7692 Intermediate Similarity NPD8434 Phase 2
0.7688 Intermediate Similarity NPD6234 Discontinued
0.7688 Intermediate Similarity NPD6651 Approved
0.7684 Intermediate Similarity NPD7435 Discontinued
0.7684 Intermediate Similarity NPD3751 Discontinued
0.7674 Intermediate Similarity NPD4967 Phase 2
0.7674 Intermediate Similarity NPD4966 Approved
0.7674 Intermediate Similarity NPD4965 Approved
0.7665 Intermediate Similarity NPD1512 Approved
0.7665 Intermediate Similarity NPD6273 Approved
0.7657 Intermediate Similarity NPD3787 Discontinued
0.7657 Intermediate Similarity NPD5710 Approved
0.7657 Intermediate Similarity NPD5711 Approved
0.7654 Intermediate Similarity NPD2796 Approved
0.7633 Intermediate Similarity NPD3226 Approved
0.7622 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7611 Intermediate Similarity NPD7240 Approved
0.7605 Intermediate Similarity NPD5401 Approved
0.7593 Intermediate Similarity NPD1510 Phase 2
0.7576 Intermediate Similarity NPD7003 Approved
0.7558 Intermediate Similarity NPD8455 Phase 2
0.7547 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD2935 Discontinued
0.7546 Intermediate Similarity NPD1551 Phase 2
0.7545 Intermediate Similarity NPD7390 Discontinued
0.7541 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7526 Intermediate Similarity NPD6779 Approved
0.7526 Intermediate Similarity NPD6778 Approved
0.7526 Intermediate Similarity NPD6776 Approved
0.7526 Intermediate Similarity NPD6782 Approved
0.7526 Intermediate Similarity NPD6777 Approved
0.7526 Intermediate Similarity NPD6781 Approved
0.7526 Intermediate Similarity NPD6780 Approved
0.7516 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD5124 Phase 1
0.7514 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7697 Approved
0.75 Intermediate Similarity NPD7698 Approved
0.75 Intermediate Similarity NPD2346 Discontinued
0.75 Intermediate Similarity NPD7696 Phase 3
0.75 Intermediate Similarity NPD8127 Discontinued
0.7485 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD3748 Approved
0.7469 Intermediate Similarity NPD1607 Approved
0.7461 Intermediate Similarity NPD8320 Phase 1
0.7461 Intermediate Similarity NPD8319 Approved
0.746 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD7229 Phase 3
0.7453 Intermediate Similarity NPD1240 Approved
0.7449 Intermediate Similarity NPD7874 Approved
0.7449 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD7701 Phase 2
0.7386 Intermediate Similarity NPD919 Approved
0.7378 Intermediate Similarity NPD2799 Discontinued
0.7371 Intermediate Similarity NPD7871 Phase 2
0.7371 Intermediate Similarity NPD7870 Phase 2
0.7365 Intermediate Similarity NPD8166 Discontinued
0.7358 Intermediate Similarity NPD6823 Phase 2
0.7356 Intermediate Similarity NPD5761 Phase 2
0.7356 Intermediate Similarity NPD5760 Phase 2
0.7348 Intermediate Similarity NPD7286 Phase 2
0.7346 Intermediate Similarity NPD4060 Phase 1
0.7333 Intermediate Similarity NPD5406 Approved
0.7333 Intermediate Similarity NPD5408 Approved
0.7333 Intermediate Similarity NPD5405 Approved
0.7333 Intermediate Similarity NPD5404 Approved
0.733 Intermediate Similarity NPD7699 Phase 2
0.733 Intermediate Similarity NPD7700 Phase 2
0.7323 Intermediate Similarity NPD7801 Approved
0.7312 Intermediate Similarity NPD4908 Phase 1
0.731 Intermediate Similarity NPD920 Approved
0.7305 Intermediate Similarity NPD1243 Approved
0.7305 Intermediate Similarity NPD6674 Discontinued
0.7301 Intermediate Similarity NPD230 Phase 1
0.7283 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7033 Discontinued
0.7268 Intermediate Similarity NPD5953 Discontinued
0.7267 Intermediate Similarity NPD4625 Phase 3
0.7263 Intermediate Similarity NPD6535 Approved
0.7263 Intermediate Similarity NPD6534 Approved
0.7262 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD1613 Approved
0.7239 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD7685 Pre-registration
0.7209 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD7177 Discontinued
0.7195 Intermediate Similarity NPD6355 Discontinued
0.7193 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD5763 Approved
0.7186 Intermediate Similarity NPD5762 Approved
0.7176 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7173 Intermediate Similarity NPD4363 Phase 3
0.7173 Intermediate Similarity NPD4360 Phase 2
0.716 Intermediate Similarity NPD7095 Approved
0.7143 Intermediate Similarity NPD7497 Discontinued
0.7135 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD4140 Approved
0.7121 Intermediate Similarity NPD7584 Approved
0.7118 Intermediate Similarity NPD6190 Approved
0.7117 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD6798 Discontinued
0.7113 Intermediate Similarity NPD8285 Discontinued
0.7108 Intermediate Similarity NPD7097 Phase 1
0.7107 Intermediate Similarity NPD4749 Approved
0.7099 Intermediate Similarity NPD6832 Phase 2
0.7095 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD447 Suspended
0.7087 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD8032 Phase 2
0.7069 Intermediate Similarity NPD1653 Approved
0.7059 Intermediate Similarity NPD4110 Phase 3
0.7059 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7056 Intermediate Similarity NPD7680 Approved
0.7053 Intermediate Similarity NPD4287 Approved
0.7044 Intermediate Similarity NPD7930 Approved
0.7044 Intermediate Similarity NPD1608 Approved
0.7037 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7033 Intermediate Similarity NPD3926 Phase 2
0.703 Intermediate Similarity NPD943 Approved
0.7024 Intermediate Similarity NPD2438 Suspended
0.7022 Intermediate Similarity NPD4288 Approved
0.7022 Intermediate Similarity NPD5353 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data